Register for our upcoming webinar:
Target Safety Assessment: from target biology to associated liabilities

10th February 2022 @4pm (GMT) / 11am (EST) / 8am (PST)

In this webinar you will learn about:

• Why invest in Target Safety Assessment Reports: challenges in target safety profiling and target safety-related drug attrition.
• Advantages of utilizing a Full-TSA in your drug development program.
• Overview of a Full-Target Safety Assessment Report.

Who should attend?

Professionals working in: pharmaceutical toxicology, chemical safety, preclinical safety, clinical development, medical biology, molecular biology

Learn about the liabilities that are potentially associated with your target to help accelerate your decision-making processes.